Current Value
$36.141 Year Return
Current Value
$36.141 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHE | 40.88% | $550.45M | 0.39% |
IXJ | 37.75% | $3.75B | 0.41% |
MOO | 37.12% | $646.81M | 0.55% |
PPH | 36.90% | $610.46M | 0.36% |
XPH | 36.85% | $147.96M | 0.35% |
VHT | 36.44% | $15.35B | 0.09% |
XLV | 36.34% | $34.28B | 0.09% |
FHLC | 36.30% | $2.44B | 0.084% |
FXH | 36.12% | $903.07M | 0.62% |
IYH | 36.02% | $2.73B | 0.39% |
RSPH | 35.94% | $729.81M | 0.4% |
EWL | 35.50% | $1.33B | 0.5% |
GCOW | 35.34% | $2.32B | 0.6% |
EWI | 33.78% | $541.53M | 0.5% |
PBE | 33.14% | $223.19M | 0.58% |
IEUR | 33.13% | $6.85B | 0.09% |
BBH | 33.07% | $330.62M | 0.35% |
PID | 32.81% | $844.81M | 0.53% |
VGK | 32.78% | $26.09B | 0.06% |
LVHI | 32.76% | $2.78B | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -18.64% | $99.63M | 0.59% |
VIXY | -18.42% | $164.54M | 0.85% |
IVOL | -17.92% | $347.03M | 1.02% |
FTSD | -17.50% | $231.81M | 0.25% |
AGZD | -12.00% | $102.70M | 0.23% |
BTAL | -9.95% | $296.22M | 1.43% |
CLIP | -9.89% | $1.51B | 0.07% |
SHYM | -9.16% | $357.13M | 0.35% |
UUP | -7.84% | $201.63M | 0.77% |
USDU | -6.70% | $162.43M | 0.5% |
KCCA | -6.51% | $109.43M | 0.87% |
TPMN | -6.46% | $30.70M | 0.65% |
TBLL | -3.31% | $2.13B | 0.08% |
PHDG | -2.89% | $90.24M | 0.39% |
CANE | -2.43% | $10.37M | 0.29% |
IBD | -2.37% | $385.27M | 0.43% |
SPTS | -1.34% | $5.80B | 0.03% |
STPZ | -1.21% | $450.47M | 0.2% |
STOT | -0.36% | $254.07M | 0.45% |
LDUR | -0.10% | $929.65M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IGMS | -17.79% | $79.35M | -79.53% | 0.00% |
AIFU | -17.46% | $6.79B | +102.19% | 0.00% |
K | -11.68% | $27.76B | +41.17% | 2.85% |
STZ | -10.86% | $30.76B | -30.55% | 2.33% |
AQB | -10.52% | $2.96M | -53.35% | 0.00% |
MCY | -10.08% | $3.65B | +24.66% | 1.92% |
MRSN | -9.06% | $34.86M | -84.80% | 0.00% |
LITB | -8.96% | $21.24M | -78.57% | 0.00% |
PRAX | -8.90% | $943.49M | +15.80% | 0.00% |
AVDL | -8.79% | $853.63M | -39.37% | 0.00% |
RLMD | -7.74% | $19.95M | -80.03% | 0.00% |
IMDX | -7.31% | $86.94M | -0.65% | 0.00% |
NEO | -6.87% | $952.34M | -46.10% | 0.00% |
XGN | -6.82% | $152.37M | +285.08% | 0.00% |
GME | -6.59% | $10.71B | -1.72% | 0.00% |
APLS | -6.39% | $2.24B | -49.68% | 0.00% |
SKYT | -6.21% | $526.01M | +48.58% | 0.00% |
QURE | -6.05% | $781.81M | +265.22% | 0.00% |
WOR | -5.92% | $3.28B | +42.32% | 1.03% |
DYN | -5.87% | $1.02B | -73.78% | 0.00% |
SeekingAlpha
Royalty Pharma: Attractive Acquisition With Upside Risk/Reward On Current Pipeline
Finnhub
Royalty Pharma plc dropped from Russell 1000 Value-Defensive Index...
Finnhub
Royalty Pharma plc dropped from Russell 1000 Defensive Index...
Yahoo
Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...
Yahoo
Royalty Pharma’s first quarter reflected a stable performance, with revenue in line with Wall Street expectations and non-GAAP profitability exceeding consensus. Management highlighted double-digit growth in recurring royalty receipts, driven by the strength of the company’s diversified portfolio and several milestone payments. CEO Pablo Legorreta attributed the results to the company’s efficient business model and active capital deployment, including the initiation of a substantial share buybac
Finnhub
PRE-QUARTERLY RESULTS COMMUNICATION NEW YORK, NY, June 27, 2025 - Royalty Pharma intends to announce its financial results for the second quarter of 2025 on August 6, 2025. To assist...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MODV | 0.01% | $45.07M | -88.46% | 0.00% |
APP | 0.03% | $113.70B | +286.38% | 0.00% |
DNB | 0.04% | $4.06B | -1.09% | 1.64% |
KROS | -0.05% | $544.65M | -68.20% | 0.00% |
TECX | -0.09% | $393.80M | +34.46% | 0.00% |
TMDX | -0.09% | $4.32B | -14.61% | 0.00% |
CCEC | 0.11% | $1.02B | +3.91% | 2.58% |
UTZ | 0.12% | $1.14B | -19.23% | 1.82% |
ASPS | 0.12% | $108.30M | -4.13% | 0.00% |
CYCN | 0.13% | $10.59M | +46.35% | 0.00% |
TAP | -0.13% | $9.53B | -2.15% | 3.67% |
KVYO | -0.15% | $9.07B | +34.36% | 0.00% |
QBTS | 0.16% | $4.99B | +1,352.73% | 0.00% |
STG | -0.16% | $30.78M | -22.51% | 0.00% |
SRRK | 0.17% | $3.38B | +357.53% | 0.00% |
NNE | -0.18% | $1.37B | +39.32% | 0.00% |
HCAT | -0.20% | $282.58M | -34.30% | 0.00% |
VERX | 0.21% | $5.50B | -2.12% | 0.00% |
FENG | -0.21% | $12.58M | -16.79% | 0.00% |
KR | -0.22% | $46.43B | +38.38% | 1.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LDUR | -0.10% | $929.65M | 0.5% |
URNM | 0.25% | $1.75B | 0.75% |
STOT | -0.36% | $254.07M | 0.45% |
SCHO | 0.49% | $11.03B | 0.03% |
WEAT | 0.81% | $117.15M | 0.28% |
STPZ | -1.21% | $450.47M | 0.2% |
NEAR | 1.29% | $3.34B | 0.25% |
BIL | 1.31% | $42.24B | 0.1356% |
SPTS | -1.34% | $5.80B | 0.03% |
XONE | 1.35% | $625.28M | 0.03% |
XBIL | 1.38% | $783.90M | 0.15% |
UTWO | 1.43% | $379.52M | 0.15% |
VGSH | 1.49% | $22.80B | 0.03% |
BNDX | 1.68% | $67.52B | 0.07% |
FLMI | 1.75% | $725.99M | 0.3% |
URNJ | 1.76% | $307.35M | 0.8% |
UGA | 1.86% | $72.33M | 0.97% |
BSMW | 1.91% | $107.45M | 0.18% |
GBIL | 1.93% | $6.37B | 0.12% |
BILS | 2.08% | $3.81B | 0.1356% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIV | 36.29% | $1.24B | +13.48% | 0.00% |
AEP | 35.11% | $55.16B | +17.93% | 3.54% |
SNX | 34.42% | $11.69B | +22.74% | 1.20% |
WBA | 34.11% | $9.95B | +3.51% | 4.36% |
EXR | 34.10% | $32.21B | -1.57% | 4.25% |
AZN | 33.42% | $220.60B | -7.38% | 2.19% |
NSA | 33.36% | $2.49B | -20.15% | 6.97% |
NVS | 31.45% | $234.94B | +15.95% | 3.27% |
ZTS | 31.29% | $70.82B | -9.41% | 1.18% |
PFE | 31.20% | $143.95B | -8.59% | 6.72% |
WY | 31.14% | $19.36B | -1.29% | 3.08% |
ALC | 30.86% | $44.17B | +1.33% | 0.38% |
DAL | 30.52% | $32.73B | +5.78% | 1.19% |
SUNS | 30.52% | $148.84M | -1.86% | 11.08% |
SYK | 30.08% | $149.74B | +18.01% | 0.85% |
GIL | 30.04% | $7.58B | +30.12% | 1.72% |
VICI | 29.80% | $35.20B | +20.04% | 5.18% |
JOE | 29.75% | $2.85B | -9.60% | 1.14% |
GSK | 29.67% | $77.95B | +0.13% | 4.18% |
NTST | 29.56% | $1.38B | +3.82% | 5.01% |
Double maintains 9 strategies that include RPRX - Royalty Pharma Plc